Jana Pourova

Dr. Jana Pourova

Faculty of Pharmacy, Charles University, Czech Republic

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
MDMartin Doležal
Martin Doležal
EJEduard Jirkovský
Eduard Jirkovský
Kateřina MacákováKateřina Macáková
Kateřina Macáková
LKLenka Kujovská Krčmová
Lenka Kujovská Krčmová
LJLenka Javorská
Lenka Javorská
OOOn Behalf Of The Oemonom
On Behalf Of The Oemonom
Vitamin C (L-ascorbic acid) has been known as an antioxidant for most people. However, its physiological role is much larger and encompasses very different processes ranging from facilitation of iron absorption through involvement in hormones and carnitine synthesis for important roles in epigenetic processes. Contrarily, high doses act as a pro-oxidant than an anti-oxidant. This may also be the reason why plasma levels are meticulously regulated on the level of absorption and excretion in the kidney. Interestingly, most cells contain vitamin C in millimolar concentrations, which is much higher than its plasma concentrations, and compared to other vitamins. The role of vitamin C is well demonstrated by miscellaneous symptoms of its absence—scurvy. The only clinically well-documented indication for vitamin C is scurvy. The effects of vitamin C administration on cancer, cardiovascular diseases, and infections are rather minor or even debatable in the general population. Vitamin C is relatively safe, but caution should be given to the administration of high doses, which can cause overt side effects in some susceptible patients (e.g., oxalate renal stones). Lastly, analytical methods for its determination with advantages and pitfalls are also discussed in this review.

5 January 2018 in Medicinal Research Reviews
Verified
Journal Article
Open access
PDF file
MLMladěnka
Mladěnka
PŘPřemysl
Přemysl
LALenka Applová
Lenka Applová
JPJiří Patočka
Jiří Patočka
Vera CostaVera Costa
Vera Costa
MSMartin Sterba
Martin Sterba
Cardiovascular diseases are a leading cause of morbidity and mortality in most developed countries of the world. Pharmaceuticals, illicit drugs, and toxins can significantly contribute to the overall cardiovascular burden and thus deserve attention. The present article is a systematic overview of drugs that may induce distinct cardiovascular toxicity. The compounds are classified into agents that have significant effects on the heart, blood vessels, or both. The mechanism(s) of toxic action are discussed and treatment modalities are briefly mentioned in relevant cases. Due to the large number of clinically relevant compounds discussed, this article could be of interest to a broad audience including pharmacologists and toxicologists, pharmacists, physicians, and medicinal chemists. Particular emphasis is given to clinically relevant topics including the cardiovascular toxicity of illicit sympathomimetic drugs (e.g., cocaine, amphetamines, cathinones), drugs that prolong the QT interval, antidysrhythmic drugs, digoxin and other cardioactive steroids, beta‐blockers, calcium channel blockers, female hormones, nonsteroidal anti‐inflammatory, and anticancer compounds encompassing anthracyclines and novel targeted therapy interfering with the HER2 or the vascular endothelial growth factor pathway.

8 December 2009 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
JPJana Pourova
Jana Pourova
MKM. Kottova
M. Kottova
MVM. Voprsalova
M. Voprsalova
MPMilan Pour
Milan Pour

21 January 2016 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
INIveta Nejmanová
Iveta Nejmanová
JPJana Pourova
Jana Pourova
MVMarie Vopršalová
Marie Vopršalová
VPVeronika Pilařová
Veronika Pilařová
VSVladimír Semecký
Vladimír Semecký
Premysl MladenkaPremysl Mladenka
Premysl Mladenka

15 February 2021 in Medicinal Research Reviews
Verified
Journal Article
Closed access
PDF file
VTVáclav Tvrdý
Václav Tvrdý
JPJana Pourova
Jana Pourova
EJEduard Jirkovský
Eduard Jirkovský
Vladimir KřenVladimir Křen
Vladimir Křen
Kateřina ValentováKateřina Valentová
Kateřina Valentová
Premysl MladenkaPremysl Mladenka
Premysl Mladenka

13 January 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
PDPatrícia Dias
Patrícia Dias
JPJana Pourova
Jana Pourova
MVMarie Vopršalová
Marie Vopršalová
INIveta Nejmanová
Iveta Nejmanová
Premysl MladenkaPremysl Mladenka
Premysl Mladenka
Regular intake of polyphenol-rich food has been associated with a wide variety of beneficial health effects, including the prevention of cardiovascular diseases. However, the parent flavonoids have mostly low bioavailability and, hence, their metabolites have been hypothesized to be bioactive. One of these metabolites, 3-hydroxyphenylacetic acid (3-HPAA), formed by the gut microbiota, was previously reported to exert vasorelaxant effects ex vivo. The aim of this study was to shed more light on this effect in vivo, and to elucidate the mechanism of action. 3-HPAA gave rise to a dose-dependent decrease in arterial blood pressure when administered i.v. both as a bolus and infusion to spontaneously hypertensive rats. In contrast, no significant changes in heart rate were observed. In ex vivo experiments, where porcine hearts from a slaughterhouse were used to decrease the need for laboratory animals, 3-HPAA relaxed precontracted porcine coronary artery segments via a mechanism partially dependent on endothelium integrity. This relaxation was significantly impaired after endothelial nitric oxide synthase inhibition. In contrast, the blockade of SKCa or IKCa channels, or muscarinic receptors, did not affect 3-HPAA relaxation. Similarly, no effects of 3-HPAA on cyclooxygenase nor L-type calcium channels were observed. Thus, 3-HPAA decreases blood pressure in vivo via vessel relaxation, and this mechanism might be based on the release of nitric oxide by the endothelial layer.